Psychiatry and Clinical Psychopharmacology
Case Report

Treatment of ADHD in a patient with Brugada syndrome: a case report and a brief review

1.

Department of Psychiatry, Sultan Abdulhamid Han Training and Research Hospital, İstanbul, Turkey

2.

Department of Psychiatry, Sultan Abdülhamid Han Training and Research Hospital, İstanbul, Türkiye

3.

Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey

Psychiatry and Clinical Psychopharmacology 2018; 28: 339-342
DOI: 10.1080/24750573.2017.1412607
Read: 1744 Downloads: 639 Published: 09 February 2021

The Brugada syndrome is one of the common causes of sudden cardiac arrest in healthyappearing adults. The use of drugs in the treatment of this disease may give variable and unwanted results. Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobehavioural disorder which has begun to be noticed in adults as much as children. In our case, we present a 39-year-old male patient with an ADHD who was diagnosed with the Brugada syndrome during a routine examination and we discuss the treatment of this case. The association of ADHD and Brugada syndrome has not been previously reported in any clinical study. As far as we know, the present case is the first article in the literature to discuss the follow-up and treatment of ADHD in a patient with the Brugada syndrome. We observed all medical and non-medical treatment methods for ADHD treatment and discussed these methods such as psychostimulants, atomoxetine, bupropion, and psychotherapy

Files
EISSN 2475-0581